LIVE TV
ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2021
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Jobs
  • Indian Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • Authors
  • More ...
    • VIDEOS
    • PHOTOS

Read in App
Business News » Companies News

Dr Reddy's Q4 net profit rises by 319%

GV Prasad, Co-Chairman and CEO of Dr Reddy's Laboratories said, “FY17 has been challenging year due to lack of new product approvals for the US market. However, our other geoghraphies delivered good performance with several new product launches.”

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
 Dr Reddy's Q4 net profit rises by 319%
A Bloomberg poll estimated Dr Reddy's net profit to be at Rs 418 crore this Q4. Photo: Pixabay
Written By: ZeeBiz WebTeam
Updated: Fri, May 12, 2017
01:41 pm
Mumbai, ZeeBiz WebDesk
RELATED NEWS
Sputnik V clinical trial is about to begin: Saumen Chakraborty, CFO, Dr Reddy’s Laboratories Sputnik V clinical trial is about to begin: Saumen Chakraborty, CFO, Dr Reddy’s Laboratories
Trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy''s Trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy''s
Dr Reddy's seeks DCGI nod for conducting phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V Dr Reddy's seeks DCGI nod for conducting phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V
Dr Reddy's Share price skyrockets near 13 pct; stock market experts suggest this strategy to mint money Dr Reddy's Share price skyrockets near 13 pct; stock market experts suggest this strategy to mint money
Stocks in Focus on September 18: Dr Reddy's, Cipla, Lupin, Happiest Minds Technologies to HDFC Bank; here are expected newsmakers of the day Stocks in Focus on September 18: Dr Reddy's, Cipla, Lupin, Happiest Minds Technologies to HDFC Bank; here are expected newsmakers of the day

Dr Reddy's Laboratories on Friday reported a whopping 319% rise in its consolidated net profit for the fourth quarter ended March 31, 2017 result. 

The company posted consolidated net profit of Rs 312.5 crore this Q4, rising by 319% compared to Rs 74.6 crore in the corresponding period of the previous year. 

A Bloomberg poll estimated Dr Reddy's net profit to be at Rs 418 crore this Q4. 

GV Prasad, Co-Chairman and CEO of Dr Reddy's Laboratories said, “FY17 has been challenging year due to lack of new product approvals for the US market. However, our other geoghraphies delivered good performance with several new product launches.”

Consolidated revenue of Dr Reddy's stood at Rs 3,554.2 crore, down 14% as against Rs 3,756.2 crore a year ago similar period.

Also Read: Dr Reddy's Laboratories Q4 review: Here's what to expect

EBITA (operating profit) stood at Rs 630.3 crore, increasing by 31.20% year-on-year (YoY). The EBIDTA margins also improved to 17.7%, expanding by 490 basis points yoy.

Meanwhile, Research & Development expenses stood at Rs 460 crore – which was 12.9% of revenues. Also SG&A expenses declines by 6% yoy to Rs 1,100 crore.

Prasad added, “We are also seeing expanded global access to our Biosimilars, as a result of successful registrations in Emerging markets. We will continue our focus on rationalisation of  cost structures and building a sustainable quality culture across the organisation.”

Share price of Dr Reddy was trading at Rs 2582.75 per piece on BSE, down Rs 10 or 0.37% at 1331 hours.
 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Dr Reddy's LaboratoriesDr Reddys Q4 resultDr Reddys Net profitDr Reddys resultsUSFDAPharmaceuticalsMarketsSharesBSEDr Reddys revenueQ4FY17FY17Dr Reddys financial performance
RELATED NEWS
Sputnik V clinical trial is about to begin: Saumen Chakraborty, CFO, Dr Reddy’s Laboratories Sputnik V clinical trial is about to begin: Saumen Chakraborty, CFO, Dr Reddy’s Laboratories
Trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy''s Trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy''s
Dr Reddy's seeks DCGI nod for conducting phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V Dr Reddy's seeks DCGI nod for conducting phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V
Dr Reddy's Share price skyrockets near 13 pct; stock market experts suggest this strategy to mint money Dr Reddy's Share price skyrockets near 13 pct; stock market experts suggest this strategy to mint money
Stocks in Focus on September 18: Dr Reddy's, Cipla, Lupin, Happiest Minds Technologies to HDFC Bank; here are expected newsmakers of the day Stocks in Focus on September 18: Dr Reddy's, Cipla, Lupin, Happiest Minds Technologies to HDFC Bank; here are expected newsmakers of the day

LATEST NEWS

M&M would list 8 of 10 growth champs in next three years: Dr. Anish Shah, Deputy MD and Group CFO

IBPS Clerk Result 2020-21: Prelims cut off declared! Check score card, latest update at ibps.in

7th Pay Commission Latest News Today 2021: Big 7th CPC announcement for central government employees; Modi government unveils this

Good News! Reliance Jio recharge plan - Rs 11 offer now has 1GB data | Check voucher details here

How to delete your phone number from TrueCaller, remove account: Follow these easy steps

Name of Gigi Hadid, Zayn Malik's daughter revealed

'Game of Thrones' prequel series Tales of Dunk and Egg in the works at HBO

A college dropout who made it to be an entrepreneur and international stock market trader with thousands of clients…

Cyient share price up 18% on strong Q3 FY21, highlights HDFC Securities

Earthquake Today: Massive magnitude 7.0 quake shakes Philippines; US Geological Survey says no tsunami warning require

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
Copyright © Zee Media Corporation Ltd. All rights reserved